Discover 1,402 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,402
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Bellevue WA, Everett WA, West Covina CA, Redlands CA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
for
Migraine
Location: Tacoma WA, Bellevue WA, Portland OR, Meridian ID,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06417775
Phase3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Tacoma WA, New Westminster, North Vancouver, Penticton,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Tacoma WA, Seattle WA, Houston TX, Canton OH,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT03260491
Phase1, Recruiting
Active & Responsive
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers
for
Leg Ulcer
Location: Tacoma WA, Carmichael CA, Las Vegas NV, Phoenix AZ,
Sponsor: Intercytex
Sex: All
Age: 18+
Code: NCT00232973
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
for
Relapsing Multiple Sclerosis (RMS)
Location: Tacoma WA, Seattle WA, Greenfield WI, Hollywood FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06869785
Phase3, Recruiting
Active & Responsive
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC